α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline–1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation

Diabetes mellitus (DM) is a multifaceted metabolic disorder that remains a major threat to global health security. Sadly, the clinical relevance of available drugs is burdened with an upsurge in adverse effects; hence, inhibiting the carbohydrate-hydrolyzing enzymes α-glucosidase and α-amylase while...

Descripción completa

Detalles Bibliográficos
Autores principales: Cele, Nosipho, Awolade, Paul, Seboletswe, Pule, Olofinsan, Kolawole, Islam, Md. Shahidul, Singh, Parvesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414972/
https://www.ncbi.nlm.nih.gov/pubmed/36015183
http://dx.doi.org/10.3390/ph15081035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414972/
https://www.ncbi.nlm.nih.gov/pubmed/36015183
http://dx.doi.org/10.3390/ph15081035

Ejemplares similares